236 related articles for article (PubMed ID: 30898090)
21. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre.
Tatarelli P; Faraci M; Caviglia I; Bandettini R; Cangemi G; Magnano GM; Garaventa A; Viscoli C; Castagnola E
Mycoses; 2017 Aug; 60(8):517-520. PubMed ID: 28429862
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.
Yong MK; Ananda-Rajah M; Cameron PU; Morrissey CO; Spencer A; Ritchie D; Cheng AC; Lewin SR; Slavin M
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1961-1967. PubMed ID: 28797778
[TBL] [Abstract][Full Text] [Related]
24. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
[TBL] [Abstract][Full Text] [Related]
25. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
26. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
[TBL] [Abstract][Full Text] [Related]
27. Yield of fungal surveillance cultures in pediatric hematopoietic stem cell transplant patients: a retrospective analysis and survey of current practice.
Youngster I; Sharma TS; Duncan CN; McAdam AJ
Clin Infect Dis; 2014 Feb; 58(3):365-71. PubMed ID: 24192388
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.
Liu J; Huang H; Li Y; Liu L; Li J; Liu Z; Lu J; Ouyang J; Song Y; Zhou D; Ren H; Ma J; Wang C; Yu L; Zhou J; Wang J; Xiao Y; Huang X; Li J
Tumour Biol; 2016 Jun; 37(6):7893-900. PubMed ID: 26700667
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.
Douglas AP; Slavin MA
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140
[TBL] [Abstract][Full Text] [Related]
30. Clinical features in proven and probable invasive fungal disease in children and adolescents at a pediatric referral center: a 5-year experience.
Kishimoto K; Kasai M; Kawamura N; Ito Y; Yoshida M; Hasegawa D; Kawasaki K; Kosaka Y
World J Pediatr; 2019 Jun; 15(3):270-275. PubMed ID: 31011987
[TBL] [Abstract][Full Text] [Related]
31. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Girmenia C; Raiola AM; Piciocchi A; Algarotti A; Stanzani M; Cudillo L; Pecoraro C; Guidi S; Iori AP; Montante B; Chiusolo P; Lanino E; Carella AM; Zucchetti E; Bruno B; Irrera G; Patriarca F; Baronciani D; Musso M; Prete A; Risitano AM; Russo D; Mordini N; Pastore D; Vacca A; Onida F; Falcioni S; Pisapia G; Milone G; Vallisa D; Olivieri A; Bonini A; Castagnola E; Sica S; Majolino I; Bosi A; Busca A; Arcese W; Bandini G; Bacigalupo A; Rambaldi A; Locasciulli A
Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738
[TBL] [Abstract][Full Text] [Related]
32. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
34. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
[TBL] [Abstract][Full Text] [Related]
35. A Retrospective Study of Central Nervous System Invasive Fungal Disease after Allogeneic Stem Cell Transplantation: Risk Factors, Clinical Characteristics, and Outcomes.
Sun YQ; Liu ZY; Huang XJ; Yan CH; Xu LP; Zhang XH; Liu KY; Wang Y
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1158-1164. PubMed ID: 28390982
[TBL] [Abstract][Full Text] [Related]
36. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
37. Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study.
Zhao C; Zhao XS; Xu LP; Zhang XH; Huang XJ; Sun YQ
BMC Infect Dis; 2022 Mar; 22(1):292. PubMed ID: 35346077
[TBL] [Abstract][Full Text] [Related]
38. Physicians' knowledge of invasive fungal disease in China.
Chen Y; Huang X; Qiu H; Cheng L; Yu Y; Ma X; Feng S; Li Q; Wu D; Huang W; Chen D; Lv X; Hu J; Wang J; Li J; Yang W; Zhan Q; Sun B; Wang M
Mycoses; 2023 Aug; 66(8):723-731. PubMed ID: 37059587
[TBL] [Abstract][Full Text] [Related]
39. Invasive Fungal Disease in Renal Transplant Recipients at a Brazilian Center: Local Epidemiology Matters.
Guimarães LF; Halpern M; de Lemos AS; de Gouvêa EF; Gonçalves RT; da Rosa Santos MA; Nucci M; Santoro-Lopes G
Transplant Proc; 2016 Sep; 48(7):2306-2309. PubMed ID: 27742285
[TBL] [Abstract][Full Text] [Related]
40. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]